Print Page  Close Window

News Release

Teleflex to Present at the 2nd Annual Congress of the European Society for Vascular Medicine (ESVM)

WAYNE, Pa.--(BUSINESS WIRE)--May 2, 2016-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its Arrow® Interventional Access Portfolio at the 2nd Annual Congress of the European Society for Vascular Medicine (ESVM) to be held in Rome, Italy on May 8 – 10, 2016.

During the event, Teleflex will highlight the Arrow® GPSCath® Balloon Dilatation Catheter featuring innovative VisioValve® Technology over a 0.014 guidewire - for infrapopliteal interventions.

The Arrow® GPSCath® Catheter is a specialty two-in-one device that is indicated for percutaneous transluminal angioplasty (PTA) in the peripheral vasculature, including iliac, femoral, popliteal, infrapopliteal and renal arteries allowing the physician to conduct angioplasty and inject fluid (targeted angiogram specifically at lesion site) while maintaining catheter and guidewire position. Below-the-knee interventions can be complex undertakings, requiring multiple devices, numerous procedural steps and significant procedural time. The Arrow® GPSCath® Catheter offers a solution by combining angioplasty and angiography into one device.

Prof. Marianne Brodmann, University Hospital Graz, Austria, will present the Arrow® GPSCath® Balloon Dilatation Catheter with a recorded live-case "Popliteal and BTK trifurcation occlusion in dialyzed diabetic Rutherford 5" on Monday May 9, at 10:09 a.m., during the Symposium: Endovascular Techniques and Arterial Revascularisation held from 09:00-10:30 a.m. in the Dali Auditorium.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck® – trusted brands united by a common sense of purpose.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, the Teleflex logo, Arrow, Deknatel, GPSCath, Hudson RCI, LMA, Pilling, Rüsch, VisioValve and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. © 2016 Teleflex Incorporated. All rights reserved.

Source: Teleflex Incorporated

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
or
Martina Teichmann-Zindler
Director Marketing Communications International
+49 (0)7151-406-538
martina.teichmann@teleflex.com